OVID - Ovid Therapeutics Inc
IEX Last Trade
1.13
-0.070 -6.195%
Share volume: 190,991
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.20
-0.07
-5.83%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-13 | 2023-05-05 | 2023-08-04 | 2023-11-03 | 2024-03-08 | 2024-05-14 | |
| Total revenue | 0.000 | 11.102 K | 46.280 K | 66.160 K | 75.000 K | 108.972 K | 141.563 K | 148.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 11.102 K | 46.280 K | 66.160 K | 75.000 K | 108.972 K | 141.563 K | 148.000 K | |
| inf% | 316.86% | 42.96% | 13.36% | 45.30% | 29.91% | 4.55% | |||
| Operating expenses | 14.304 M | 12.815 M | 12.219 M | 14.958 M | 14.247 M | 12.138 M | 18.330 M | 17.565 M | |
| Selling general and admin | 8.258 M | 7.632 M | 6.663 M | 8.344 M | 8.248 M | 6.805 M | 7.688 M | 7.168 M | |
| Research and development | 6.047 M | 5.183 M | 5.556 M | 6.615 M | 5.999 M | 5.333 M | 10.642 M | 10.397 M | |
| Total expenses | 14.304 M | 12.815 M | 12.219 M | 14.958 M | 14.247 M | 12.138 M | 18.330 M | 17.565 M | |
| -10.41% | -4.65% | 22.42% | -4.76% | -14.80% | 51.02% | -4.17% | |||
| Operating income | -14.304 M | -12.804 M | -12.173 M | -14.892 M | -14.172 M | -12.029 M | -18.188 M | -17.417 M | |
| Ebit | -14.304 M | -12.804 M | -12.173 M | -14.892 M | -14.172 M | -12.029 M | -18.188 M | -17.417 M | |
| Pretax income | -14.588 M | -11.968 M | -11.505 M | -13.356 M | -12.408 M | -11.252 M | -15.322 M | -11.694 M | |
| -17.96% | -3.87% | 16.09% | -7.10% | -9.32% | 36.17% | -23.68% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -14.588 M | -11.968 M | -11.505 M | -13.356 M | -12.408 M | -11.252 M | -15.322 M | -11.694 M | |
| 17.96% | 3.87% | -16.09% | 7.10% | 9.32% | -36.17% | 23.68% | |||
| Net income | -14.588 M | -11.968 M | -11.505 M | -13.356 M | -12.408 M | -11.252 M | -15.322 M | -11.694 M | |
| 17.96% | 3.87% | -16.09% | 7.10% | 9.32% | -36.17% | 23.68% |